FOXP3 and breast cancer: Implications for therapy and diagnosis

Pharmacogenomics

Volumn 8, Issue 11, 2007, Pages 1485-1487

  Liu, Yang ^a   Zheng, Pan ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR; TRANSCRIPTION FACTOR FOXP3;

BREAST CANCER; CANCER INHIBITION; CANCER RISK; CANCER THERAPY; CHROMOSOME DELETION; EDITORIAL; EXON; GENE DISRUPTION; GENE EXPRESSION; GENE INACTIVATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENE SILENCING; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; HUMAN; NEPHROBLASTOMA; NONHUMAN; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE; X CHROMOSOME LINKAGE;

BREAST NEOPLASMS; CHROMOSOMES, HUMAN, X; ENZYME REACTIVATORS; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE SILENCING; HUMANS; POLYMORPHISM, GENETIC; RECEPTOR, ERBB-2; X CHROMOSOME INACTIVATION;

EID: 37349075877     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/14622416.8.11.1485     Document Type: Editorial

References (22)

1. Chatila TA, Blaeser F, Ho N et al.: JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest. 106(12), R75-R81 (2000).
2. Brunkow ME, Jeffery EW, Hjerrild KA et al.: Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27(1), 68-73 (2001).
3. Bennett CL, Christie J, Ramsdell F et al.: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27(1), 20-21 (2001).
4. Wildin RS, Ramsdell F, Peake J et al.: X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat. Genet. 27(1), 18-20 (2001).
5. + regulatory T-cells. Nat. Immunol. 4, 330-334 (2003).
6. Chang X, Gao JX, Jiang Q et al.: The Scurfy mutation of FoxP3 in the thymus stroma leads to defective thymopoiesis. J. Exp. Med. 202(8), 1141-1151 (2005).
7. Zuo T, Wang L, Morrison C et al.: FOXP3 is an X-linked breast cancer suppressor gene and an important repressor of HER-2/ErbB2 oncogene. Cell 129, 1275-1286 (2007).
8. Zuo T, Liu R, Zhang H et al.: FOXP3 is a novel transcription repressor for the breast cancer oncogene SKP2. J. Clin. Invest. (2007) (In press).
9. Spatz A, Borg C, Feunteun J: X-chromosome genetics and human cancer. Nat. Rev. Cancer 4(8), 617-629 (2004).
10. Medina D, Kittrell FS, Shepard A, Contreras A, Rosen JM, Lydon J: Hormone dependence in premalignant mammary progression. Cancer Res. 63(5), 1067-1072 (2003).
11. Monroe KR, Yu MC, Kolonel LN et al.: Evidence of an X-linked or recessive genetic component to prostate cancer risk. Nat. Med. 1(8), 827-829 (1995).
12. Xu J, Meyers D, Freije D et al.: Evidence for a prostate cancer susceptibility locus on the X chromosome. Nat. Genet. 20(2), 175-179 (1998).
13. Kibel AS, Faith DA, Bova GS, Isaacs WB: Xq27-28 deletions in prostate carcinoma. Genes Chromosomes Cancer 37(4), 381-388 (2003).
14. Bochum S, Paiss T, Vogel W, Herkommer K, Hautmann R, Haeussler J: Confirmation of the prostate cancer susceptibility locus HPCX in a set of 104 German prostate cancer families. Prostate 52(1), 12-19 (2002).
15. Roncuzzi L, Brognara I, Cocchi S, Zoli W, Gasperi-Campani A: Loss of heterozygosity at pseudoautosomal regions in human breast cancer and association with negative hormonal phenotype. Cancer Genet. Cytogenet. 135(2), 173-176 (2002).
16. Piao Z, Malkhosyan SR: Frequent loss Xq25 on the inactive X chromosome in primary breast carcinomas is associated with tumor grade and axillary lymph node metastasis. Genes Chromosomes Cancer 33(3), 262-269 (2002).
17. Jiang F, Richter J, Schraml P et al.: Chromosomal imbalances in papillary renal cell carcinoma: genetic differences between histological subtypes. Am. J. Pathol. 153(5), 1467-1473 (1998).
18. Rivera MN, Kim WJ, Wells J et al.: An X chromosome gene, WTX, is commonly inactivated in Wilms tumor. Science 315(5812), 642-645 (2007).
19. Csankovszki G, Nagy A, Jaenisch R: Synergism of Xist RNA, DNA methylation, and histone hypoacetylation in maintaining X chromosome inactivation. J. Cell Biol. 153(4), 773-784 (2001).
20. Hernandez-Munoz I, Lund AH, van der Stoop P et al.: Stable X chromosome inactivation involves the PRC1 polycomb complex and requires histone MACROH2A1 and the CULLIN3/SPOP ubiquitin E3 ligase. Proc. Natl Acad. Sci. USA 102(21), 7635-7640 (2005).
21. Tan J, Yang X, Zhuang L et al.: Pharmacologic disruption of polycomb-repressive complex 2-mediated gene repression selectively induces apoptosis in cancer cells. Genes Dev. 21(9), 1050-1063 (2007).
22. Kalantry S, Mills KC, Yee D, Otte AP, Panning B, Magnuson T: The polycomb group protein EED protects the inactive X-chromosome from differentiation-induced reactivation. Nat. Cell Biol. 8(2), 195-202 (2006).